unctad.org | Development Dimensions of Intellectual Property Rights
Development Dimensions of Intellectual Property Rights

TOT-IP logo Responding to the new mandate received from Member States at the Ministerial Conference in Doha, as well as to the requests contained in the WIPO Development Agenda and the World Health Assembly´s Resolution 61.21 on a Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property, the UNCTAD Secretariat is implementing a work programme on the development dimensions of intellectual property (IP) rights.

The IP programme conducts research and analysis on trade and development aspects of intellectual property and facilitates consensus-building in international discussions on issues at the interface between investment and intellectual property.   More >

 

 News

 
Flag of Japan
16 August 2012Panel to focus on Japan's regulation of technology licensing agreements
A panel discussion is being organised for Monday, 3 September at the Palais des Nations in Geneva to focus on how Japan has applied competition policy in the regulation of technology licensing agreements during the post-War period.​
Investment in Pharmaceutical Production in the Least Developed Countries
08 May 2011UNCTAD report says least developed countries in position to improve access to medicines through local production
Events shaping the global pharmaceutical industry provide an unprecedented opportunity for the least developed countries (LDCs) to attract investment in the pharmaceutical sector, including from other developing countries, a new UNCTAD report contends. With the right set of policies in place, LDCs can use the local production of pharmaceuticals to help ensure greater access to essential medicines, the study says.
access to medicines through local production
08 May 2011UNCTAD report says least developed countries in position to improve access to medicines through local production
Events shaping the global pharmaceutical industry provide an unprecedented opportunity for the least developed countries (LDCs) to attract investment in the pharmaceutical sector, including from other developing countries, a new UNCTAD report contends. With the right set of policies in place, LDCs can use the local production of pharmaceuticals to help ensure greater access to essential medicines, the study says.​
Development Dimensions of Intellectual Property Rights
05 April 2011International Conference on Local Pharmaceutical Production in Africa
UNCTAD, the United Nations Industrial Development Organization (UNIDO), and the German Federal Ministry for Economic Cooperation and Development (BMZ) hosted a conference on local pharmaceutical production in Africa, from 4-6 April 2011.
19 Dec 08 - Balancing health concerns and pharmaceutical patents
Secretary-General reaffirms intellectual property framework critical for production of drugs in developing countries
6 - 10 of 12
 
 
 

 Publications

 
The Development Dimensions of Intellectual Property in Nepal - Transfer of Technology, Access to Medicines, Genetic Resources and Traditional Knowledge (UNCTAD/DIAE/PCB/2015/7)
22 Sep 2016, 59 page(s), 4158.5 KB
TRIPS Flexibilities and Anti-Counterfeit Legislation in Kenya and the East African Community: Implications for Generic Producers - An UNCTAD-UNIDO Discussion Paper (UNCTAD/DIAE/PCB/2015/6)
14 Sep 2016, 5426.9 KB
Intellectual property: How much room is left for industrial policy? by Carlos M. Correa - UNCTAD Discussion Paper No. 223 (UNCTAD/OSG/DP/2015/5)
06 Nov 2015, 336.0 KB
The Convention on Biodiversity and the Nagoya Protocol: Intellectual Property Implications - A Handbook on the Interface between Global Access and Benefit Sharing Rules and Intellectual Property (UNCTAD/DIAE/PCB/2014/3)
01 Oct 2014, 214 page(s), 1805.2 KB
Local Production of Pharmaceuticals and Related Technology Transfer in Developing Countries: A series of case studies (UNCTAD/DIAE/PCB/2011/7)
19 Sep 2012, 2944.2 KB
1 - 5 of 18
 
 

 Events and Meetings

 
Tab Control
Intellectual Property
Outputs
Loading..

Please wait....

_ _ Charlie Hebdo